Cullinan Oncology Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you, everyone, for joining us today. Today is the last day of JP Morgan's 40th Annual Healthcare Conference. My name is Tarun Soni, I'm a Vice President in JPMorgan's Healthcare Investment Banking Group.
Before I introduce you to our presenter for the session, I want to call your attention to the blue button on your screen which says ask a question. You may submit your questions here, and I can address it during the Q&A session.
With that, I'm very pleased to introduce you to Nadim Ahmed, CEO of Cullinan Oncology. I know he's very excited to tell you a little bit about the story. So over to you, Nadim.
Good morning, Tarun, and everyone watching. It's great to be with you today. And so let me start out by providing a little strategic background to Cullinan Oncology as a company. So starting with Slide 3. If I can move it. So we have a very broad and deep pipeline. So we now have 8 programs across multiple platforms and multiple indications
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
